In this study, we demonstrated that tirzepatide reversed PSD95 and SYT1 loss in the hippocampus of diabetics (Figures 4A–C), suggest that tirzepatide’s ability to restore memory is related to its effect on synaptic function. This evidence concerns the gene DLG4 and diabetes mellitus.